ransparent_placeh Platinum playing crucial anti-cancer role, making major pharmaceutical contribution
https://newsletter.mw.creamermedia.com
Africa|Business|Energy|Health|Mining|Platinum|Projects|Renewable Energy|Renewable-Energy|Service|Storage|Systems|Technology|Water|Products|Solutions
Africa|Business|Energy|Health|Mining|Platinum|Projects|Renewable Energy|Renewable-Energy|Service|Storage|Systems|Technology|Water|Products|Solutions
africa|business|energy|health|mining|platinum|projects|renewable-energy|renewable-energy-company|service|storage|systems|technology|water|products|solutions

Platinum playing crucial anti-cancer role, making major pharmaceutical contribution

Platinum-based pharmaceutical ingredients form the backbone of cancer treatment through chemotherapy.

Platinum-based ingredients form the backbone of cancer treatment through chemotherapy.

More than two-million chemotherapy cycles.

Platinum-based highly potent active pharmaceutical ingredients, or HPAPIs.

Heraeus EVP Business Line Hydrogen Systems Dr Philipp Walter.

29th January 2025

By: Martin Creamer

Creamer Media Editor

     

Font size: - +

JOHANNESBURG (miningweekly.com) – Platinum group metals (PGMs), which are hosted overwhelmingly in South Africa, are playing a crucial anti-cancer role as well as making a significant overall PGM contribution to the pharmaceuticals sector.

This has been highlighted by Heraeus Precious Metals, following its acquisition of the platinum-based active pharmaceutical ingredient (API) business of Umicore outside of South America.

According to the World Health Organisation, cancer is the cause of nearly one in six deaths and, alarmingly, this number is expected to rise further.

The demand for platinum-based highly potent active pharmaceutical ingredients (HPAPIs) is on the rise with the number of new cancer cases worldwide predicted to increase from 21.9-million this year to 30.2-million in 2040.

Besides their presence in HPAPIs, PGMs are also very helpful for the synthesis of sophisticated API molecules. HPAPIs are described as the key compounds in chemotherapy because they can target cancer cells accurately, Heraeus informs Mining Weekly.

PGMs company Heraeus Precious Metals in 2023 played a role in around 2.3-million cycles of chemotherapy, involving more than 450 000 patients.

Platinum-based Cisplatin and Carboplatin anti-cancer drugs work primarily by binding with DNA.

Additionally, these drugs can induce oxidative stress and potentially modulate the immune response, enhancing the recognition of cancer cells.

Since the 1970s, Heraeus has been selling a broad portfolio of oncology APIs from Germany to the world.

Platinum APIs, especially Cisplatin, Carboplatin and Oxaliplatin, form the backbone of cancer treatment through chemotherapy.

PLATINUM IN COATINGS FOR ELECTROLYSIS

Earlier this month, Heraeus also signed a memorandum of understanding with Jolt Solutions, a Barcelona-based company specialising in the coating of metallic catalysts for electrochemical applications, to optimize the use of PGMs for proton exchange membrane (PEM) water electrolysis, using Jolt’s proprietary SparkfuzeTM technology.

This faster coating method with low energy demands is scalable and produces surfaces with high catalytic activity and durability.

The two companies aim to explore the use of PGM-based metallic catalysts for PEM water electrolysis. Heraeus Precious Metals sees synergies between the two companies. Whilst utilizing Jolt’s patented electrode production technique to produce electrochemical products, the precious metals expert can use its specialties in PGM trading, hedging, PGM sourcing, recycling and recovery to create a valuable closed loop product offering.

Heraeus EVP Business Line Hydrogen Systems Dr Philipp Walter said Jolt’s technology competence and ability to tackle and quickly scale development projects is “a very good fit to our know-how and service portfolio around PGM applications”.

“We’re looking forward to exploring new business opportunities together,” was the comment of Jolt Solutions CEO Leon Rizzi.

Meanwhile, PEM electrolysers are gaining increasing traction in the transition to a hydrogen economy owing to their dynamic response time.

The production of green hydrogen through PEM electrolysis of water is seen as a very suitable concept to enable storage, transportation and deployment of the produced renewable energy.

Edited by Creamer Media Reporter

Comments

Showroom

Rittal
Rittal

Rittal is a world leading provider of top-quality integrated systems for enclosures, power distribution, climate control, IT infrastructure and...

VISIT SHOWROOM 
John Thompson
John Thompson

John Thompson, the leader in energy and environmental solutions through value engineering and innovation, provides the following: design, engineer,...

VISIT SHOWROOM 

Latest Multimedia

sponsored by

Photo of Martin Creamer
On-The-Air (24/01/2025)
24th January 2025 By: Martin Creamer

Option 1 (equivalent of R125 a month):

Receive a weekly copy of Creamer Media's Engineering News & Mining Weekly magazine
(print copy for those in South Africa and e-magazine for those outside of South Africa)
Receive daily email newsletters
Access to full search results
Access archive of magazine back copies
Access to Projects in Progress
Access to ONE Research Report of your choice in PDF format

Option 2 (equivalent of R375 a month):

All benefits from Option 1
PLUS
Access to Creamer Media's Research Channel Africa for ALL Research Reports, in PDF format, on various industrial and mining sectors including Electricity; Water; Energy Transition; Hydrogen; Roads, Rail and Ports; Coal; Gold; Platinum; Battery Metals; etc.

Already a subscriber?

Forgotten your password?

MAGAZINE & ONLINE

SUBSCRIBE

RESEARCH CHANNEL AFRICA

SUBSCRIBE

CORPORATE PACKAGES

CLICK FOR A QUOTATION







sq:0.356 0.448s - 350pq - 2rq
Subscribe Now